ESIH:F:F-Ishares VI PLC - Ishares Msci Europe Health Care Sector Ucits ETF (EUR)

ETF | Others |

Last Closing

USD 6.311

Change

-0.10 (-1.59)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.77 (-1.46%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.85 (-1.47%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.22 (-1.37%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

+0.02 (+0.28%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

+0.34 (+0.34%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+3.35 (+1.45%)

USD 45.80B
0ZC:F Zscaler Inc

+2.35 (+1.08%)

USD 37.92B
BSND:F Danone SA

-0.20 (-1.41%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+0.26 (+0.20%)

USD 24.77B

ETFs Containing ESIH:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.28% 31% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.28% 31% F 44% F
Trailing 12 Months  
Capital Gain -11.08% 13% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -11.08% 11% F 32% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.82% 51% F 54% F
Dividend Return 4.82% 48% F 46% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.93% 81% B- 96% N/A
Risk Adjusted Return 69.53% 70% C- 77% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.